Clinical Trials Sponsored by Xu Lei

Total 5899 results

LEO Pharma

Completed

Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects

Skin and Connective Tissue Diseases

Japan
LEO Pharma

Completed

Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Scalp Psoriasis

United States
LEO Pharma

Completed

The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris

Psoriasis Vulgaris

Japan
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel Compared With Tacalcitol Ointment and the Gel Vehicle Alone in Patients With Psoriasis Vulgaris

Psoriasis Vulgaris

Canada
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Psoriasis of Scalp

Canada, Denmark, France, Norway, Portugal, Spain, Sweden, United Kingdom
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Cream and (Calcipotriol + Betamethasone Dipropionate) Ointment in Psoriasis Vulgaris

Psoriasis Vulgaris

Belgium, Canada, France, Germany, Netherlands, Spain, United Kingdom
LEO Pharma

Completed

Efficacy of Calcipotriol Plus Betamethasone Gel Versus Calcipotriol Scalp Solution in Scalp Psoriasis

Psoriasis of Scalp

France, Canada, Belgium, Denmark, Sweden
LEO Pharma

Completed

Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris

Psoriasis Vulgaris

Ireland, Germany, United Kingdom, Canada, Sweden
LEO Pharma

Completed

Efficacy and Safety of Calcipotriene/Betamethasone Gel/Ointment in Psoriasis

Psoriasis

United States
LEO Pharma

Completed

Topical Treatment of Scalp Psoriasis With the Fixed Combination of Calcipotriol and Betamethason (Xamiol® Gel)

Scalp Psoriasis

Germany
LEO Pharma

Completed

The Impact of Renal Impairment on the Pharmacokinetic and Pharmacodynamic of LEO 27847

Renal Impairment

Canada
LEO Pharma

Completed

LEO 22811 - Single Dose Bioavailability Study of Tablet Versus Oral Solution in Healthy Subjects

Healthy

United Kingdom
LEO Pharma

Completed

Assessment of the Phototoxic Potential of LEO 29102 Cream

Atopic Dermatitis

France
LEO Pharma

Completed

A Safety, Tolerability and Pharmacokinetic Study of LEO 29102 in Subjects With Atopic Dermatitis

Atopic Dermatitis

Netherlands
LEO Pharma

Terminated

Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.

Atopic Dermatitis

Germany
LEO Pharma

Terminated

Cromoglicate in Mastocytosis

Mastocytosis

Germany
Zhang Lei

Recruiting

A Prospective, One-arm and Open Clinical Study of Zanubrutinib in the Treatment of Immune Thrombocytopenia

Immune Thrombocytopenia | Treatment

China
Zhang Lei

Recruiting

Evaluation of Immune Status Before and After Splenectomy in Immune Thrombocytopenia Patients

Thrombocytopenia | Splenectomy

China
Institut de Recherche Clinique sur les Cancers...
Pfizer

Completed

Toxicity/Benefit Ratio Optimization of Chemotherapy in Colorectal Cancer (CRC) Patients by Determination of Individual Genotypic Determinants

Metastatic Colorectal Cancer

France
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company; Genentech, Inc.

Terminated

Phase I/II Trial of Bevacizumab, Pemetrexed and Erlotinib in Elderly Patients With Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer

United States
H. Lee Moffitt Cancer Center and Research Institute
Eli Lilly and Company; Aventis Pharmaceuticals

Completed

The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

United States
Douglas Mental Health University Institute
Réseau québécois sur le suicide, les troubles de l'humeur et les troubles...

Completed

Music as an Intervention to Improve Hemodynamic Tolerability of Ketamine in Depression

Depressive Disorder, Major | Depressive Disorder, Treatment-Resistant | Unipolar Depression | Depression, Bipolar

Canada
Zhang Lei, MD

Recruiting

Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

Thrombocytopenia | Antiphospholipid Syndrome | Treatment

China
LEO Pharma
LEO Pharma GmbH, Neu-Isenburg, Germany

Completed

Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

Psoriasis Vulgaris

Germany
MEI Pharma, Inc.

Recruiting

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)

United States
MEI Pharma, Inc.

Active, not recruiting

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Colorectal Cancer

United States
LEO Pharma
Bayer

Completed

Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis

Dermatitis, Atopic
LEO Pharma
Bayer

Completed

A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

Seborrheic Dermatitis on the Face

Germany
LEO Pharma
Bayer

Completed

Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

Perioral Dermatitis

Germany
LEO Pharma
Bayer

Completed

A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily

Papulopustular Rosacea

Germany
Leti Pharma GmbH

Completed

Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients

Allergic Asthma | Allergic Rhinoconjunctivitis

Germany
LEO Pharma
Bayer

Completed

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

Rosacea

United States
LEO Pharma
Bayer

Completed

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

Healthy

United States
LEO Pharma
Bayer

Completed

A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea

Rosacea

United States
LEO Pharma
Bayer

Completed

Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

Papulopustular Rosacea

United States
Laboratorios Leti, S.L.

Terminated

Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract

Allergic Asthma

Spain
Leti Pharma GmbH

Completed

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma | Sensitization Against Betula Alba (Birch) Pollen

Germany
Laboratorios Leti, S.L.

Completed

Biological Standardization of Platanus Acerifolia Allergen Extract

Allergy to Platanus Acerifolia

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract

Allergic Rhinitis | Allergic Asthma | Allergy Dermatophagoides Pteronyssinus

Spain
MEI Pharma, Inc.

Completed

OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer (OVATURE)

Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer

United States, Spain, Belgium, United Kingdom, Australia, Italy, Poland
MEI Pharma, Inc.

Completed

Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States, Australia
Laboratorios Leti, S.L.

Completed

Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)

Allergy to Tree Pollen

Spain
Laboratorios Leti, S.L.

Completed

Biological Potency of the Cat Epithelial Allergenic Extracts

Cat Allergy (Disorder)

Spain
Laboratorios Leti, S.L.

Completed

Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).

Allergy | Rhinitis | Rhinoconjunctivitis | Seasonal Asthma

Spain
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

Seasonal Allergic Rhinitis

Spain, Hungary
Leti Pharma GmbH

Completed

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma | Sensitization Against Phleum Pratense Pollen | Dose-Finding Study

Germany
Laboratorios Leti, S.L.

Completed

Biological Standardization of Blomia Tropicalis Allergen Extract

Allergy to Mites

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Dactylis Glomerata Allergen Extract

Allergy to Grass Pollen (Dactylis Glomerata)

Spain
Laboratorios Leti, S.L.

Completed

Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis (GPIT)

Allergic Rhinoconjunctivitis

South Africa

3

Subscribe